Press release
Rising incidences of chronic inflammatory and autoimmune diseases has increased the need of anti-inflammatory therapeutics Market
According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.Get the sample Report: https://www.alliedmarketresearch.com/request-sample/1175?utm_source=openpr_Niranjan
Inflammation is a nonspecific immune defense mechanism of the body triggered due to injuries, bacterial or viral infections or any damage to the internal or external organs. When this inflammation persists for longer duration it can lead to chronic diseases such as atherosclerosis and rheumatoid arthritis, to name few. Currently, reduction of inflammation particularly in chronic diseases is the widely accepted therapeutic approach adopted by physicians.
Rising incidences of autoimmune and respiratory diseases, increasing R&D investments in China and India and a large number of biosimilar drugs in the development pipeline would drive the growth of the Asia-Pacific anti-inflammatory therapeutics market. Furthermore, factors such as the existence of established markets for NSAIDs and corticosteroids, large adoption of OTC (over the counter) NSAIDs, such as ibuprofen and naproxen, in China and India and government initiatives in the Asia-Pacific region would further boost the market growth. However, the adverse effects associated with prolonged consumption of drugs such as NSAIDs and corticosteroids and issues of uncertain patent legislation, such as compulsory licensing in India, would limit market growth. High price sensitivity in countries such as India and China would be the key challenge for drug innovators to launch their patented drugs in the market.
Purchase the Report @ Discount: https://www.alliedmarketresearch.com/checkout/180310?utm_source=openpr_Niranjan
The anti-inflammatory biologics segment dominated the market in 2014 and is expected to display the highest growth rate over the forecast period. This is due to the unmatched benefits offered by biological drugs and rapid adoption in countries like Japan along with improving healthcare access and increasing healthcare expenditures. The popularity of corticosteroids has been decreasing due to the issues of withdrawal symptoms and toxicity.
Key Findings of the Anti-inflammatory Therapeutics Asia-Pacific Market:
China is expected to take over Japan by 2018 in the Asia Pacific anti-inflammatory therapeutics market. India anti-inflammatory therapeutics market is projected to account for around 13% share in the Asia-Pacific market by 2020. China and India would govern around half of the Asia-Pacific NSAID market by 2020. Japan accounted for around 1/3rd share in the anti-inflammatory biologics market in 2014, the highest among all Arthritis indication was the major revenue-generating segment in the APAC anti-inflammatory indication market in 2014. Psoriasis indication is projected to grow at a CAGR of 10.7%, fastest among all indications.
Japan is the leading market for patented as well as biologic drugs. However, a government in Japan is now focusing on the establishment of effective generic drugs. On the other hand, China is projected to emerge as the new market leader in the Asia-Pacific anti-inflammatory therapeutics market by 2020 due to the rapidly developing economy, growing healthcare expenditure and huge patient base. In India, the launch of biosimilars and constantly improving per capita healthcare spending would be the key factors facilitating the growth of anti-inflammatory therapeutics market.
Companies have been adopting strategies such as collaborations, indication expansions, and product launches as their key strategies to overcome the patent expiry issues of existing drugs and to gain additional market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc. Novartis AG, F. Hoffman La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen, Inc.
About Us:-
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Us:-
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Rising incidences of chronic inflammatory and autoimmune diseases has increased the need of anti-inflammatory therapeutics Market here
News-ID: 1469578 • Views: …
More Releases from Allied Market Research

Cream Powder Market to Reach $8.9 Billion by 2031 with 6.4% CAGR
The global cream powder industry was estimated at $4.8 billion in 2021 and is expected to hit $8.9 billion by 2031, registering a CAGR of 6.4% from 2022 to 2031.
The cream powder market is experiencing growth due to various factors, including the increasing popularity of bakeries and HoReCa (hotels, restaurants, and cafes) and rising consumer demand for natural products. The dairy-based segment is a significant contributor to the market's growth…

Micro Drone Market Valued at $6.71 Billion in 2020, Expected to Reach $28.91 Bil …
The global micro drone industry generated $6.71 billion in 2020, and is expected to reach $28.91 billion in 2030, witnessing a CAGR of 17.2% from 2021 to 2030. The report provides an extensive analysis of changing market dynamics, top segments, top investment pockets, regional landscape, value chain, and competitive scenario.
Increased operational efficiency and rise in demand for improved surveillance drive the growth of the global micro drone market. However, strict…

Microwavable Foods Market to reach $230.93 billion by 2031, growing at a CAGR of …
The global microwaveable foods industry was accounted for $120.45 billion in 2020, and is expected to reach $230.93 billion by 2031, growing at a CAGR of 5.6% from 2022 to 2031.
Rise in popularity of fast-food restaurants and large population base coupled with increase in number of quick-service restaurants drive the global microwaveable foods market. However, lack of awareness about microwavable foods hinders the market growth. On the contrary, rise in…

Bluetooth 5.0 Market is Projected to Grow Expeditiously: to Reach $11.7 Billion …
As per the report, the global Bluetooth 5.0 market was accounted for $4.2 billion in 2021, and is expected to reach $11.7 billion by 2031, growing at a CAGR of 10.9% from 2022 to 2031.
Bluetooth 5.0 is the newest overarching innovation of Bluetooth, it is the wireless, close-range technology found in smartphones, smartwatches, tablets, wireless headphones and speakers, laptops, desktop computers, and more.
Request Sample Report (Get Full Insights in…
More Releases for Asia
GlobalTech Horizons Asia (GTH-Asia) Expands Operations to Strengthen Regional Pr …
GTH-Asia Launches Strategic Expansion to Enhance Investment and Technological Growth Across Key Asian Markets.
GlobalTech Horizons Asia (GTH-Asia), the regional arm of GlobalTech Horizons Group (GTH-Group), announces the launch of its operations across Asia, reinforcing its commitment to driving economic development, fostering strategic investments, and pioneering industry-leading innovations in financial and business sectors.
With Asia continuing to solidify its position as a global economic powerhouse, GTH-Asia is strengthening its regional presence by…
Asia-Pacific Power Transformer (
Transforming energy with efficiency and reliability, power transformers play a crucial role in the transmission and distribution of electricity. From stepping up voltage for long-distance transmission to stepping down voltage for distribution to homes and businesses, these essential devices form the backbone of electrical infrastructure worldwide. Let's explore the latest advancements and innovations in power transformer technology.rs.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬:
https://www.alliedmarketresearch.com/request-sample/4548
As the world shifts towards greener energy solutions, sustainability…
Asia-Pacific Indapamide Market
Asia-Pacific indapamide market is estimated to grow significantly at a CAGR of around 3.8% during the forecast period owing to the increasing prevalence of chronic disorders, including hypertension, CVD, and diabetes. The rising incidences of these diseases have been reported in several countries of Asia-Pacific, including China, India, and Singapore. For instance, in India, one in five young adults has high blood pressure, according to the data presented at the…
Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value.
https://boomingfaucet.com/
Asia Private Equity Consulting
E-mail:nolan@pandacuads.com
In China,…
Asia Pacific Marine Battery
A recent report published by Astute Analytica gives an overview of the current situation of the Asia Pacific Marine Battery Market. The market study's anticipated years are 2022 to 2026.
The Asia Pacific Marine Battery Market size will grow from US$ 123.9 million in 2021 to US$ 1,017.1 million by 2026, growing at a (CAGR) of 51.1% during the forecast period 2022 to 2026.
The research study offers important market data, including…
Asia-Pacific Hazardous Lighting Market 2021 Growth Outlook - ABB Asia Pte. Ltd., …
The Asia-Pacific Hazardous Lighting Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The Asia-Pacific Hazardous Lighting…